NCT03460977 2026-03-13A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPfizerPhase 1 Recruiting453 enrolled
NCT05602597 2024-03-06HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPIHutchmedPhase 1 Completed59 enrolled
NCT05720767 2023-03-01HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer StudyHutchmedPhase 1 Completed28 enrolled